Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Art Vandelay who wrote (7961)	8/4/1999 9:38:00 PM
From: jeffbas	Respond to of 78825

COO: I still like the company a lot. I call it a growth stock at a value price, what in the old day's was called a "businessman's risk" investment. They should make estimates of $.45 for the quarter ending 7/31. Estimates are $1.90 for the FY starting 11/1/99. It pays no taxes because of large NOL's but reports on a fully-taxed basis. Company operates in the higher growth Toric contact lens market where it will soon be number 1, and is gaining market share. Company would be an attractive acquisition target for JNJ and others. They bought back 6% of the outstanding shares at $15+ recently, and would start another buyback under 20, in my opinion. Yahoo thread is the main thread and is pretty decent. Coverage by 3 firms, probably going to 5 soon, major institutional ownership, minor dividend. If anyone had an interest, and owned none, I would suggest a 1/3 position at today's prices (20 1/2+), 1/3 if it is dragged down 2 points by a general market fall, and 1/3 at around 16. My target is high 30's over a couple of years either through company performance or a takeover. Eighteen month price range 52-12. A fabulous run got carried away and it was overpriced at $52. A less optimistic view of the industry, hot money going to the laser eye surgery stocks, and some now-solved company specific problems at the end of last fiscal year and the beginning of the current one took it to $12. Since hitting 12 has rallied to as high as 25.